ESC 365 - Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial

ESC Professional Premium Access

Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial

Session: Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation

Topic: No Reflow

Speaker: Professor I. Eitel (Luebeck, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Ingo Eitel

University Heart Center, Luebeck (Germany)

13 presentations

0 follower

3 more presentations in this session

Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.

Speaker: Doctor L. Rasmussen (Herning, DK)

Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial

Speaker: Doctor J. Haener (Bern, CH)

Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.

Speaker: Doctor J. De La Torre Hernandez (Santander, ES)

Access the full session

Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation

Speakers: Professor I. Eitel, Doctor L. Rasmussen, Doctor J. Haener, Doctor J. De La Torre Hernandez

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources